Britain’s competition watchdog has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost of an epilepsy drug, given to more than 50,000 British patients, by as much as 2,600%.

Views on just what good-value hotel deals online bookers are getting are being sought by fair trading chiefs in the UK.

Drugs giant GlaxoSmithKline was today accused by the UK's competition watchdog of paying off firms to delay the launch of cheap versions of its antidepressant treatment in a move that denied the British National Health Service “significant” cost savings.

The UK's Office of Fair Trading (OFT) today launched an investigation into the impact on the cost of medicines to patients and the NHS after Pfizer’s controversial deal to sell drugs in the UK solely through one wholesaler.